aspenpharma.com

Revisión web de aspenpharma.com

Aspen Pharmacare | Pharmaceutical Company

 Generado el 12 Marzo 2026 17:36 PM

Resultados antiguos? ACTUALIZAR !

La puntuación es 57/100

Contenido SEO

Título

Aspen Pharmacare | Pharmaceutical Company

Longitud : 41

Perfecto, tu título contiene entre 10 y 70 caracteres.

Descripción

Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets

Longitud : 131

Genial, tu descripción meta contiene entre 70 y 160 caracteres.

Palabras Claves (Keywords)

Muy mal. No hemos encontrado palabras clave (meta keywords) en tu página. Usa este generador de meta tags gratuito para crear tus palabras clave.

Propiedades Meta Og

Bien. Tu página usa propiedades Og (etiquetas og).

Propiedad Contenido
locale en_US
type website
title Aspen Pharmacare | Pharmaceutical Company
description Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets
url https://www.aspenpharma.com/
site_name Aspen Pharmacare
image https://www.aspenpharma.com/wp-content/uploads/2023/02/aspen-pharma-vials-home-1.png
image:width 496
image:height 656
image:type image/png

Titulos

H1 H2 H3 H4 H5 H6
0 62 65 10 60 30
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Healthcare. We Care.
  • [H2] Investor Hub
  • [H2] Stephen Saad (61)
  • [H2] Sean Capazorio (60)
  • [H2] Reginald Haman (52)
  • [H2] Kuseni Dlamini 58
  • [H2] Ben Kruger (66)
  • [H2] Linda de Beer (56)
  • [H2] Neo Dongwana (53)
  • [H2] Themba Mkhwanazi (56)
  • [H2] Chris Mortimer (65)
  • [H2] Yvonne Muthien (69)
  • [H2] David Redfern (59)*
  • [H2] Raeesa Khan (35)
  • [H2] Stephen Saad (61)
  • [H2] Gus Attridge (64)
  • [H2] Sean Capazorio (60)
  • [H2] Lorraine Hill (62)
  • [H2] Reginald Haman (51)
  • [H2] Samer Kassem (51)
  • [H2] Pauline Macdonald (49)
  • [H2] Trevor Ziman (54)
  • [H2] Chris Botha (47)
  • [H2] Raeesa Khan (35)
  • [H2] Stavros Nicolaou (60)
  • [H2] Carnie van der Linde (56)
  • [H2] Aspen Key Facts
  • [H2] Latest News
  • [H2] Our Purpose
  • [H2] Our Vision
  • [H2] Our Values
  • [H2] About Aspen
  • [H2] We Care
  • [H2] Careers
  • [H2] Contact Us
  • [H2] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.
  • [H2] Corporate
  • [H2] View our teams below:
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.
  • [H3] Healthcare. We Care. Excellence Integrity Healthcare. We Care. Innovation Commitment Teamwork
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] FY2026 Interim Results Booklet
  • [H3] FY2026 Interim Results Short Form Announcement
  • [H3] Our Heritage
  • [H3] Fact Sheet
  • [H3] Interim Results Presentation
  • [H3] Illustrative Revenue Disclosure
  • [H3] Interim Results Booklet
  • [H3] Interim Results Booklet – Excel Download
  • [H3] Interim Results Presentation Webcast
  • [H3] Interim Results Short Form Announcement
  • [H3] Stakeholder Update Call Presentation 15 January 2026
  • [H3] Stakeholder Update Call Webcast 15 January 2026
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Social and Ethics Committee Report
  • [H3] Notice of AGM
  • [H3] Integrated Report
  • [H3] Audit & Risk Committee Report
  • [H3] Integrated Report – View Online Version
  • [H3] Carbon Disclosure Project – Climate Change and Water Security
  • [H3] Equity Report – Pharmacare Workforce Profile
  • [H3] IBIS Assurance Statement
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Sustainability Materiality Assessment
  • [H3] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H3] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H3] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H3] Aspen highlights the rising diabetes disease burden
  • [H3] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H3] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H3] Aspen delivers strong results and advances its strategic ambitions
  • [H3] Aspen announces local availability of Lilly’s Mounjaro
  • [H3] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H3] Aspen to participate in the Investec CEO conference in London
  • [H3] Aspen Ireland gets recognised for their efforts in diversity
  • [H3] Shining the spotlight on trailblazers in Science this International Women’s Day
  • [H3] Aspen North America Region’s Aspen Canada certified as a Great Place to Work®
  • [H3] Aspen continues to demonstrate its unwavering commitment to our various communities
  • [H3] Aspen partners with Reach for a Dream to bring joy to children with rare diseases 
  • [H3] Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status
  • [H3] Aspen recognised for EY Excellence in Integrated Reporting Award
  • [H3] Closed Period
  • [H4] Board of Directors
  • [H4] Group Executive Committee
  • [H4] Financial Results
  • [H4] Integrated Reporting
  • [H4] Sustainability Documents
  • [H4] Interim Results
  • [H4] Additional Presentations and webcasts
  • [H4]  
  • [H4] Annual Financial Statements
  • [H4] Access to Medicines Position Paper
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] Stephen Saad(61)
  • [H5] Sean Capazorio(60)
  • [H5] Reginald Haman(52)
  • [H5] Kuseni Dlamini(58)
  • [H5] Ben Kruger(66)
  • [H5] Linda de Beer(56)
  • [H5] Neo Dongwana(53)
  • [H5] Themba Mkhwanazi(56)
  • [H5] Chris Mortimer(65)
  • [H5] Yvonne Muthien(69)
  • [H5] David Redfern(59)
  • [H5] Raeesa Khan(35)
  • [H5] Stephen Saad(61)
  • [H5] Gus Attridge(64)
  • [H5] Sean Capazorio(60)
  • [H5] Lorraine Hill(62)
  • [H5] Reginald Haman(52)
  • [H5] Samer Kassem(51)
  • [H5] Pauline Macdonald(49)
  • [H5] Trevor Ziman(54)
  • [H5] Chris Botha(47)
  • [H5] Raeesa Khan(35)
  • [H5] Stavros Nicolaou(60)
  • [H5] Carnie van der Linde(56)
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Find out more
  • [H6] To improve the health and quality of life of patients.
  • [H6] Find out more
  • [H6] To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.
  • [H6] Find out more
  • [H6] Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Imagenes

Hemos encontrado 91 imágenes en esta web.

51 atributos alt están vacios o no existen. Agrega texto alternativo para que los motores de búsqueda puedan entender las imágenes.

Ratio Texto/HTML

Ratio : 13%

El ratio entre texto y código HTML de esta página es menor que el 15 por ciento, esto significa que tu web posiblemente necesite más contenido en texto.

Flash

Perfecto, no se ha detectado contenido Flash en la página.

Iframe

Genial, no se han detectado Iframes en la página.

Reescritura URL

Bien. Tus enlaces parecen amigables

Guiones bajos en las URLs

Perfecto! No hemos detectado guiones bajos en tus URLs

Enlaces en página

Hemos encontrado un total de 92 enlaces incluyendo 0 enlace(s) a ficheros

Ancla Tipo Jugo
About Aspen Interna Pasando Jugo
Corporate Governance Interna Pasando Jugo
Regional Overview Interna Pasando Jugo
Manufacturing Interna Pasando Jugo
Interim Results Presentation Webcast Interna Pasando Jugo
FY2026 Interim Results Presentation Interna Pasando Jugo
Investor Relations Interna Pasando Jugo
Careers Interna Pasando Jugo
Aspen Holding News Interna Pasando Jugo
Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment Interna Pasando Jugo
Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion Interna Pasando Jugo
Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award Interna Pasando Jugo
Aspen highlights the rising diabetes disease burden Interna Pasando Jugo
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified Interna Pasando Jugo
Aspen celebrates 15 years of commitment to Nelson Mandela Day Interna Pasando Jugo
Aspen delivers strong results and advances its strategic ambitions Interna Pasando Jugo
Aspen announces local availability of Lilly’s Mounjaro Interna Pasando Jugo
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day Interna Pasando Jugo
Aspen to participate in the Investec CEO conference in London Interna Pasando Jugo
Aspen partners with PinkDrive to mobilise cancer screening Interna Pasando Jugo
Aspen’s revenue increases 10% underpinned by a strong second half performance Interna Pasando Jugo
Contact Us Interna Pasando Jugo
FY2026 Interim Results Booklet Interna Pasando Jugo
FY2026 Interim Results Short Form Announcement Interna Pasando Jugo
Fact Sheet Interna Pasando Jugo
Interim Results Presentation Interna Pasando Jugo
Illustrative Revenue Disclosure Interna Pasando Jugo
Interim Results Booklet Interna Pasando Jugo
Interim Results Booklet – Excel Download Interna Pasando Jugo
Interim Results Presentation Webcast Interna Pasando Jugo
Interim Results Short Form Announcement Interna Pasando Jugo
Stakeholder Update Call Presentation 15 January 2026 Interna Pasando Jugo
Stakeholder Update Call Webcast 15 January 2026 Interna Pasando Jugo
Annual Financial Statements Interna Pasando Jugo
Sustainability and ESG Data Supplement Interna Pasando Jugo
Social and Ethics Committee Report Interna Pasando Jugo
Notice of AGM Interna Pasando Jugo
Integrated Report Interna Pasando Jugo
Audit & Risk Committee Report Interna Pasando Jugo
Integrated Report – View Online Version Interna Pasando Jugo
Access to Medicines Position Paper Interna Pasando Jugo
Carbon Disclosure Project – Climate Change and Water Security Interna Pasando Jugo
Equity Report – Pharmacare Workforce Profile Interna Pasando Jugo
IBIS Assurance Statement Interna Pasando Jugo
Sustainability Materiality Assessment Interna Pasando Jugo
Aspen Ireland gets recognised for their efforts in diversity Interna Pasando Jugo
Shining the spotlight on trailblazers in Science this International Women’s Day Interna Pasando Jugo
Aspen North America Region’s Aspen Canada certified as a Great Place to Work® Interna Pasando Jugo
Aspen continues to demonstrate its unwavering commitment to our various communities Interna Pasando Jugo
Aspen partners with Reach for a Dream to bring joy to children with rare diseases  Interna Pasando Jugo
Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status Interna Pasando Jugo
Aspen recognised for EY Excellence in Integrated Reporting Award Interna Pasando Jugo
Disclaimer Interna Pasando Jugo
General Privacy Notice Externo Pasando Jugo
Aspen PAIA & POPI Manual Externo Pasando Jugo
Standard Terms of purchase of goods or services (STC) Externo Pasando Jugo
Australia Interna Pasando Jugo
China Externo Pasando Jugo
New Zealand Externo Pasando Jugo
Philippines Externo Pasando Jugo
Austria Externo Pasando Jugo
France Externo Pasando Jugo
France – NDB Externo Pasando Jugo
Netherlands Externo Pasando Jugo
Netherlands – Oss Externo Pasando Jugo
Russia Externo Pasando Jugo
Spain Externo Pasando Jugo
Switzerland Externo Pasando Jugo
MENAT Externo Pasando Jugo
Canada Externo Pasando Jugo
USA Externo Pasando Jugo
Brazil Interna Pasando Jugo
Mexico Externo Pasando Jugo
Ghana Externo Pasando Jugo
Kenya Externo Pasando Jugo
Mauritius Externo Pasando Jugo
Nigeria Externo Pasando Jugo
South Africa – SA Commercial Externo Pasando Jugo
South Africa – FCC Externo Pasando Jugo
South Africa HQ Externo Pasando Jugo
Tanzania Externo Pasando Jugo
EME Externo Pasando Jugo
France Externo Pasando Jugo
Germany Externo Pasando Jugo
Human Capital Interna Pasando Jugo
Legal Interna Pasando Jugo
Supply Chain Interna Pasando Jugo
Treasury Interna Pasando Jugo
Ethics & Compliance Interna Pasando Jugo
Risk & Sustainability Interna Pasando Jugo
Digital Technology Interna Pasando Jugo
Tax Interna Pasando Jugo

Palabras Clave SEO

Nube de Palabras Clave

aspen appointed business more group results read classification executive qualifications

Consistencia de las Palabras Clave

Palabra Clave (Keyword) Contenido Título Palabras Claves (Keywords) Descripción Titulos
aspen 61
group 41
more 35
appointed 29
read 27

Usabilidad

Url

Dominio : aspenpharma.com

Longitud : 15

Favicon

Genial, tu web tiene un favicon.

Imprimibilidad

Genial. Hemos encontrado una hoja de estilos CSS para impresión.

Idioma

Genial. Has declarado el idioma en.

Dublin Core

Esta página no usa Dublin Core.

Documento

Tipo de documento (Doctype)

HTML 5

Codificación

Perfecto. Has declarado como codificación UTF-8.

Validez W3C

Errores : 0

Avisos : 0

Privacidad de los Emails

Genial. No hay ninguna dirección de email como texto plano!

HTML obsoleto

Genial, no hemos detectado ninguna etiqueta HTML obsoleta.

Consejos de Velocidad

Excelente, esta web no usa tablas.
Muy mal, tu web está usando estilos embenidos (inline CSS).
Muy mal, tu página web usa demasiados ficheros CSS (más de 4).
Muy mal, tu sitio usa demasiados ficheros JavaScript (más de 6).
Su sitio web se beneficia del tipo de compresión gzip. ¡Perfecto!

Movil

Optimización Móvil

Icono para Apple
Etiqueta Meta Viewport
Contenido Flash

Optimización

Mapa del sitio XML

¡Perfecto! Su sitio tiene un mapa del sitio en XML.

https://www.aspenpharma.com/sitemap_index.xml

Robots.txt

https://aspenpharma.com/robots.txt

¡Estupendo! Su sitio web tiene un archivo robots.txt.

Herramientas de Analítica

No disponible

No hemos encontrado ninguna herramienta de analítica en esta web.

La analítica Web le permite medir la actividad de los visitantes de su sitio web. Debería tener instalada al menos una herramienta de analítica y se recomienda instalar otra más para obtener una confirmación de los resultados.

PageSpeed Insights

Dispositivo
Categorias

Free SEO Testing Tool

Free SEO Testing Tool es una herramienta seo gratuita que te ayuda a analizar tu web